Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.2100 (0.76%) ($12.8700 - $13.3400) on Thu. Nov. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 58 | Latest Price | $13.2100(0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.075% in a week (0% probabilities). VIXM(-36%) VXX(-35%) TLT(-12%) UNG(-7%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
5 Day Moving Average | $13.15(0.46%) | 10 Day Moving Average | $12.88(2.56%) | 20 Day Moving Average | $12.5(5.68%) | To recent high | -18.7% | To recent low | 21.3% | Market Cap | $982m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |